Preferred Label : nicergoline;

MeSH definition : An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.; An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS.;

MeSH synonym : nimergoline; nicotergoline;

CISMeF synonym : pharmacia brand of nicergoline; hormosan brand of nicergoline; reig jofre brand of nicergoline; betapharm brand of nicergoline; pfizer brand of nicergoline; nicergoline pfizer brand; aventis brand of nicergoline; kenfarma brand of nicergoline; lindopharm brand of nicergoline; ct-Arzneimittel brand of nicergoline; ct arzneimittel brand of nicergoline; neuraxpharm brand of nicergoline; ratiopharm brand of nicergoline; teva brand of nicergoline; nicergoline teva brand; hexal brand of nicergoline; nicergoline hexal brand; krewel brand of nicergoline; dexcel brand of nicergoline;

MeSH hyponym : ergobel; sermion; fisifax; nicergobeta; nicerium; nicergolin-neuraxpharm; nicergolin lindo; nicergolin atid; nicergolin von ct; Circo-Maren; Nicergolin-TEVA; nicergolin-ratiopharm; F.I. 6714; Von Ct, Nicergolin; Nicergolin Neuraxpharm; Nicergolin Ratiopharm; Nicergolin TEVA; Circo Maren;

MeSH CAS label : Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-;

MeSH Related Number : 27848-84-6 (Nicergoline);

Registry Number MeSH : 27848-84-6;

Wikipedia link : https://en.wikipedia.org/wiki/Nicergoline;

Codes EINECS : 248-694-6;

Is substance : O;

UNII : JCV8365FWN;

InChIKey : YSEXMKHXIOCEJA-FVFQAYNVSA-N;

Details


Main resources

You can consult :

An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.
An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS.

http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65469223
2012
France
summary of product characteristics
package leaflet
capsules
nicergoline

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67286434
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66842401
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62709898
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64881245
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65919300
2012
France
summary of product characteristics
package leaflet
capsules
nicergoline

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64407934
2012
France
summary of product characteristics
package leaflet
capsules
nicergoline

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66662549
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66868061
2012
France
summary of product characteristics
package leaflet
capsules
nicergoline

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61286317
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66425888
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63792854
2012
France
summary of product characteristics
package leaflet
nicergoline
capsules

---
http://www.has-sante.fr/portail/jcms/c_1172473/sermion
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/sermion_14-12-2011_avis_ct11854_2012-01-10_11-29-4_611.pdf
http://www.has-sante.fr/portail/jcms/c_1189007/nicergoline-mylan
http://www.has-sante.fr/portail/jcms/c_1188934/nicergoline-ranbaxy
http://www.has-sante.fr/portail/jcms/c_1188949/nicergoline-biogaran
http://www.has-sante.fr/portail/jcms/c_1188977/nicergoline-qualimed
http://www.has-sante.fr/portail/jcms/c_1188983/nicergoline-teva
http://www.has-sante.fr/portail/display.jsp?id=c_523469
2011
France
French
drugs, generic
nootropic agents
nicergoline
administration, oral
vasodilator agents
nicergoline
insurance, health, reimbursement
cognition disorders
adult
aged
intermittent claudication
vision disorders
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_449351
2006
France
evaluation of the transparency committee
capsules
nicergoline

---
http://www.has-sante.fr/portail/display.jsp?id=c_449383
2006
France
evaluation of the transparency committee
capsules
nicergoline

---
http://www.has-sante.fr/portail/display.jsp?id=c_449393
2006
France
evaluation of the transparency committee
nicergoline
capsules

---
http://www.has-sante.fr/portail/display.jsp?id=c_449405
2006
France
evaluation of the transparency committee
nicergoline
capsules

---
http://www.has-sante.fr/portail/display.jsp?id=c_449412
2006
France
evaluation of the transparency committee
nicergoline
capsules

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.